Your browser doesn't support javascript.
loading
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari.
Lacalamita, Rosanna; Quaranta, Antonio; Trisorio Liuzzi, Maria Pia; Nigro, Aldo; Simonetti, Umberto; Schirone, Massimiliano; Aloè, Ferruccio; Capochiani, Gianluca; De Francesco, Genoveffa; Gadaleta, Cosimo; Galetta, Domenico; Grammatica, Luciano; Guarini, Attilio; Mattioli, Vittorio; Milella, Piero; Moschetta, Antonio; Nardulli, Patrizia; Nigro, Vincenza; Silvestris, Nico; Paradiso, Angelo.
Afiliação
  • Lacalamita R; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Quaranta A; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Trisorio Liuzzi MP; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Nigro A; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Simonetti U; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Schirone M; TQM Management, Bari - Italy.
  • Aloè F; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Capochiani G; Azienda Sanitaria Locale, Local Health Authority, Bari - Italy.
  • De Francesco G; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Gadaleta C; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Galetta D; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Grammatica L; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Guarini A; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Mattioli V; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Milella P; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Moschetta A; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Nardulli P; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Nigro V; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Silvestris N; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
  • Paradiso A; Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Institute, Bari - Italy.
Tumori ; 101 Suppl 1: S14-8, 2015.
Article em En | MEDLINE | ID: mdl-27096266
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article